Trial
NCT00159757
12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
Schizophrenia
Intervention
ziprazidone
Why stopped
See Detailed Description for Termination Reason
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-21